Trial Profile
Clinical Study of Switching From rHuEPO to R744 and Maintenance Treatment With R744 in Renal Anemia Patients on Hemodialysis (Phase Ⅲ Study)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Jun 2022
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 30 Sep 2014 New trial record